New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.
XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback